Categories
Locations
Alabama
Alaska Alberta Arizona Arkansas British Columbia California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisana Maine Manitoba Maryland/DC Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Brunswick New Hampshire New Jersey New Mexico New York Newfoundland & Labrador North Carolina North Dakota Northwest Territories Nova Scotia Nunavut Ohio Oklahoma Ontario Oregon Pennsylvania Prince Edwards Island Quebec Rhode Island Saskatchewan South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Yukon ISO Standards
13485
13485:2003 14000 14001 14001:2004 17025 17025:2005 18001 9000 9000:2000 9000:2001 9000:2008 9001 9001:2000 9001:2001 9001:2008 9001:2015 9002 AS9100 AS9100:2009 AS9100:2009C AS9100B AS9100C QS9000 TS16949 TS16949:2002 TS16949:2009 Specialty
Woman Owned
Minority Owned Veteran Owned Ownership
All Types
Public Private Distribution
All Areas
International National Regional Local Searching IndustryNet for drug candidate suppliers.Related Searches:
|
Drug Candidates PharmaceuticalsOTHER SUPPLIERS
IndustryNet is the industrial marketplace (Page 1 of 3)
List of verified suppliers of smoking cessation aid drug candidates in Phase II & Phase III clinical trials & contract manufacturing of private label cigarettes & filtered cigars for domestic & international distribution, smoking cessation candidates in Phase I-III clinical trials, pharmaceutical drug candidates for glaucoma in Phase III clinical trials, II & III clinical trials, biopharmaceutical drug candidates in Phase I & II clinical trials, anticancer biopharmaceuticals, drug candidates for Alzheimer's disease in Phase II clinical trials, proprietary vaccine formulations, enhanced therapeutic drug candidates for certain cancers, infectious diseases & CNS disorders in Phase III clinical trials, pharmaceutical immuno-oncology drug candidates in preclinical & Phase I & II clinical trials, novel oral & intravenous drug candidates in preclinical & Phase I clinical trials for the treatment of serious & life-threatening invasive fungal infections in humans, small molecule pharmaceutical drug candidates in Phase II & III clinical trials, cancer & inflammatory diseases, II & pivotal clinical trials for treatment of hereditary angioedema & Ebola & Marburg virus infections, cancer pharmaceutical drug candidates in Phase I & II clinical trials, analytical & formulation development, cGMP manufacturing, labeling & distribution, pharmaceutical drug candidates for dermatology, anti-inflammatory & antibiotic applications, pharmaceutical drug candidates for the treatment of inflammation in Phase I clinical trials, oncology biopharmaceuticals in preclinical & Phase II clinical trials, pharmaceutical drug candidates for the treatment of staph aureus bacteremia & monoclonal antibodies in Phase II clinical trials, anticancer drug candidates in Phase III clinical trials, antihypoxia drug candidates for applications in Phase II clinical trials, cancer treatment therapy drugs & CLIA-certified predictive diagnostics for guiding treatment of blood cancers, oncology drug candidates in Phase II & III clinical trials, formulation development & clinical trial drug candidates for the pharmaceutical & biotechnology industries, oncology drug candidates in Phase I & II clinical trials, neoantigen-based oncological immunotherapy product candidates in Phase I clinical trials.
Need help? IndustryNet is powered by real people. Contact us for assistance.
|